◼ Archived
Business
🔮 fades ✗
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
Deerfield-backed startup Boulevard Bio launches with $65M and a trio of immunology drugs targeting autoimmune cures.